Showing results (21-30 of 175) with videos related to

Sort By:
Pageof 18
Acta Medica Okayama|August 24, 2016
Effect of Vandetanib on Lung Tumorigenesis in Transgenic Mice Carrying an Activating Egfr Gene MutationMasahiro Osawa, Kadoaki Ohashi, Toshio Kubo, et al.
Experimental Cell Research|January 1, 2013
Vandetanib is effective in EGFR-mutant lung cancer cells with PTEN deficiencyHiromasa Takeda, Nagio Takigawa, Kadoaki Ohashi, et al.
Molecular Cancer Therapeutics|June 30, 2011
Liposomal delivery of MicroRNA-7-expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitor-resistance in lung cancer cellsKammei Rai, Nagio Takigawa, Sachio Ito, et al.
Japanese Journal of Clinical Oncology|June 13, 2019
Efficacy of afatinib treatment for lung adenocarcinoma harboring exon 18 delE709_T710insD mutationYoshitaka Iwamoto, Eiki Ichihara, Naofumi Hara, et al.
Experimental Cell Research|January 21, 2014
Src mediates ERK reactivation in gefitinib resistance in non-small cell lung cancerNobuaki Ochi, Nagio Takigawa, Daijiro Harada, et al.
Internal Medicine (Tokyo, Japan)|January 8, 2013
A definite case of (L)-carbocisteine-induced pneumonia with CATCH22 syndromeKenichiro Kudo, Eiki Ichihara, Akiko Hisamoto, et al.
BMC Nephrology|April 3, 2020
Pembrolizumab-induced hypothyroidism caused reversible increased serum creatinine levels: a case reportNatsumi Matsuoka, Kenji Tsuji, Eiki Ichihara, et al.
Internal Medicine (Tokyo, Japan)|May 21, 2025
Remarkable Efficacy of Capmatinib in a Patient with Cancer of Unknown Primary with MET Amplification: A Case ReportTakaaki Tanaka, Go Makimoto, Ryohei Sumii, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
Re-administration of osimertinib in osimertinib-acquired resistant non-small-cell lung cancerEiki Ichihara, Katsuyuki Hotta, Kiichiro Ninomiya, et al.
Cancer Science|October 17, 2012
Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapyToshio Kubo, Nagio Takigawa, Masahiro Osawa, et al.
Pageof 18